AXOGUARD NERVE CAP
Device
AXOGEN
Total Payments
$323,226
Transactions
119
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $92,771 | 26 | 0 |
| 2023 | $45,074 | 7 | 0 |
| 2022 | $48,756 | 17 | 0 |
| 2020 | $136,626 | 69 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $323,226 | 119 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends (REPOSE-XL) | AXOGEN | $164,017 | 0 |
| Study of Axoguard Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain (REPOSE) | AXOGEN | $158,091 | 0 |
| Study of AxoGuard Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain (REPOSE) | AXOGEN | $1,118 | 0 |
Top Doctors Receiving Payments for AXOGUARD NERVE CAP
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | St George, UT | $323,226 | 119 |
About AXOGUARD NERVE CAP
AXOGUARD NERVE CAP is a device associated with $323,226 in payments to 0 healthcare providers, recorded across 119 transactions in the CMS Open Payments database. The primary manufacturer is AXOGEN.
Payment data is available from 2020 to 2024. In 2024, $92,771 was paid across 26 transactions to 0 doctors.
The most common payment nature for AXOGUARD NERVE CAP is "Unspecified" ($323,226, 100.0% of total).
AXOGUARD NERVE CAP is associated with 3 research studies, including "Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends (REPOSE-XL)" ($164,017).